|
Chaitan is the scientific founder of Alvine Pharmaceuticals and the Wells H. Rauser and Howard M. Petiprin Professor of Chemisty, Chemical Engineering, and Biochemistry at Stanford University. Dr. Khosla’s research is focused at the interface of protein chemistry and medicine. His laboratory has ongoing projects aimed at understanding the molecular basis of Celiac sprue and developing therapeutic approaches to treat the disease. He has authored over 200 scientific publications and is the recipient of numerous awards. He is a founder and director of Kosan Biosciences, a public biotechnology company (NASDAQ: KOSN) that discovers and develops new polyketide therapeutics. In 2002, he founded the non-profit Celiac Sprue Research Foundation, and served as its President until 2005. Chaitan holds a Ph.D. from the California Institute of Technology. | 